Gene Validity Curation

Gene Validity Classification Summary

Gene/Disease Pair:

MAX : Hereditary pheochromocytoma-paraganglioma

HGNC:6913 | OrphaNet: 29072 | OMIM:154950
Mode of Inheritance: Autosomal dominant inheritance (HP:0000006)

Genetic Evidence
Case-Level Data
Evidence Type Case Information Type Guidelines Scores PMIDs/Notes
Default Range Max Points Tally
Variant Evidence
Autosomal Dominant or X-linked Disorder Variant is de novo 2 0-3 12
Proband with predicted or proven null variant 1.5 0-2 10 8.0 8
Comino-Méndez I et al. 2011 Jun 19 (PMID:21685915); Burnichon N et al. 2012 May 15 (PMID:22452945); Pęczkowska M et al. 2013 Dec (PMID:23551045); Rattenberry E et al. 2013 Jul (PMID:23666964);
Proband with other variant type with some evidence of gene impact 0.5 0-1.5 7 7.0 7
Comino-Méndez I et al. 2011 Jun 19 (PMID:21685915); Burnichon N et al. 2012 May 15 (PMID:22452945); Rattenberry E et al. 2013 Jul (PMID:23666964);
Autosomal Recessive Disease Two variants in trans and at least one de novo or a predicted/proven null variant 2 0-3 12
Two variants (not predicted/proven null) with some evidence of gene impact in trans 1 0-1.5
Segregation Evidence Evidence of segregation in one or more families LOD Score Examples 3 5 0-7 7 2.0 2
Comino-Méndez I et al. 2011 Jun 19 (PMID:21685915);
2 4
1.5 3
1 1.5
   
Case-Control Data
Case-Control Study Type Case-Control Quality Criteria Guidelines Scores PMIDs/Notes
Points/Study Max Points Tally
Single Variant Analysis 1. Variant Detection Methodology
2. Power
3. Bias and confounding
4. Statistical Significance
0-6 12
Aggregate Variant Analysis 0-6 12
Total Genetic Evidence Points (Maximum 12) 12
Experimental Evidence
Evidence Category Evidence Type Guidelines Scores PMIDs/Notes
Default Range Max Points Tally
Function Biochemical Function 0.5 0 - 2 2 2.0 2
Comino-Méndez I et al. 2011 Jun 19 (PMID:21685915); Burnichon N et al. 2012 May 15 (PMID:22452945); Qin N et al. 2014 Nov 1 (PMID:24676840);
Protein Interaction 0.5 0 - 2
Expression 0.5 0 - 2
Functional Alteration Patient cells 1 0 - 2 2 2.0 2
Comino-Méndez I et al. 2011 Jun 19 (PMID:21685915); Rapizzi E et al. 2012 Jun (PMID:22323561); Qin N et al. 2014 Nov 1 (PMID:24676840);
Non-patient cells 0.5 0 - 1
Models & Rescue Animal model 2 0 - 4 4 3.0 3
Hopewell R et al. 1995 Jul (PMID:7791753);
Cell culture model system 1 0 - 2
Rescue in animal model 2 0 - 4
Rescue in engineered equivalent 1 0 - 2
Total Experimental Evidence Points (Maximum 6) 6

Assertion criteria Genetic Evidence (0-12 points) Experimental Evidence
(0-6 points)
Total Points
(0-18)
Replication Over Time (Y/N)
Description Case-level, family segregation, or case-control data that support the gene-disease association Gene-level experimental evidence that support the gene-disease association Sum of Genetic & Experimental
Evidence
> 2 pubs w/ convincing evidence over time (>3 yrs)
Assigned Points 12 6 18 YES
CALCULATED CLASSIFICATION LIMITED 1-6
MODERATE 7-11
STRONG 12-18
DEFINITIVE 12-18 AND replication over time
Valid contradictory evidence (Y/N)*
CALCULATED CLASSIFICATION (DATE)
DEFINITIVE
06/22/2017
EXPERT CURATION (DATE)
DEFINITIVE
06/22/2017
Assertion made by the Hereditary Cancer Working Group.